T. Rowe Price Investment Management, Inc. Third Harmonic Bio, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,929,498 shares of THRD stock, worth $10.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,929,498
Previous 2,830,248
3.51%
Holding current value
$10.2 Million
Previous $38.4 Million
21.4%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding THRD
# of Institutions
93Shares Held
40.2MCall Options Held
100Put Options Held
0-
Atlas Venture Life Science Advisors, LLC10.4MShares$36.1 Million17.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$20.1 Million1.61% of portfolio
-
General Atlantic LLC New York, NY3.37MShares$11.7 Million1.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$11 Million1.53% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.51MShares$8.69 Million4.21% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $140M